Microbix & Copan Italia Execute Strategic Agreement MISSISSAUGA, Ontario and BRESCIA, Italy, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix ®), a life sciences innovator and exporter, and Copan Italia S.p.A. (Copan ®), the global leader in specimen collection technologies, announce their execution of a strategic agreement (Agreement) in relation to Microbix’s quality assessment products (QAPs™) and Copan’s flocked devices (FLOQ ®). The Agreement between Microbix and Copan expands upon an existing purchase and supply contract, adding licensing of Copan’s issued patents for use of flocked devices to format test controls (broadly known as QAPs). Also, it formalizes the parties’ agreement for joint usage of their respective brands for marketing of novel and innovative QAPs – Combining Copan’s well-known FLOQ